Page 4 - Mark Fielding News Today

Thirty per cent of infertility cases relate solely to the male, but the topic is rarely aired

London Market Insurers Underperformance Looks Overdone 1205 GMT - The underperformance of London-listed insurers is overdone and this provides a strong buying opportunity into Lancashire... | June 15, 2023

The FTSE 100 Index closed up 0.3% to 7628 points, outperforming its European peers after a hawkish rate hike from the European Central Bank, with gains in health care, energy and consumer staples helping to offset the weakness in basic resources and fi...

In a research note published by Mark Fielding, RBC advises its customers to buy the stock. The target price remains unchanged at EUR 185. | May 26, 2023

Canadian bank RBC raised its price target for Siemens to 185 euros from 160 euros amid raised targets and kept its rating at outperform. Analyst Mark Fielding sees upside for growth and margins in a... | May 25, 2023

Already positive, the research from RBC and its analyst Mark Fielding still consider the stock as a Buy opportunity. Previously set at EUR 160, the target price has been raised to EUR 185. | May 25, 2023

Already positive, the research from RBC and its analyst Mark Fielding still consider the stock as a Buy opportunity. The target price is unchanged at EUR 160. | May 17, 2023

In his latest research note, analyst Mark Fielding confirms his positive recommendation. The broker RBC is keeping its Buy rating. The target price is unchanged at EUR 160. | May 3, 2023

RBC analyst Mark Fielding reiterate his Sell rating on the stock. The target price remains set at EUR 31. | May 3, 2023

Mark Fielding from RBC retains his positive opinion on the stock with a Buy rating. The target price is still set at CHF 35.50. | May 3, 2023